Alexandros Makriyannis

Has grant

Director

Northeastern University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Training Program on Development of Medications for Substance Use Disorder

Open Date: 2022-07-01

Close Date: 2027-06-30

Grant: Close

CB1 Neutral Antagonists for Alcohol Use Disorder

Open Date: 2020-09-20

Close Date: 2026-08-31

Grant: Close

Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid

Open Date: 2020-07-01

Close Date: 2026-05-31

Grant: Close

Lead Optimization of Peripheral CB1 Neutral Antagonists for Renal Diseases

Open Date: 2019-09-01

Close Date: 2021-08-31

Grant: Close

Medications for Synthetic Cannabinoid Abuse

Open Date: 2019-03-01

Close Date: 2022-02-28

Articles (21)

Year:

2026

Year:

2025

Year:

2025

Virtual library docking can reveal unexpected chemotypes that complement the structures of biological targets. Seeking agonists for the cannabinoid-1 receptor (CB1R), we dock 74 million tangible molecules and prioritize 46 high ranking ones for de novo synthesis and testing. Nine are active by radioligand competition, a 20% hit-rate. Structure-based optimization of one of the most potent of these (K i = 0.7 µM) leads to ‘1350, a 0.95 nM ligand and a full CB1R agonist of G i/o signaling. A cryo-EM structure of ‘1350 in complex with CB1R-G i1 confirms its predicted docked pose. The lead agonist is strongly analgesic in male mice, with a 2-20-fold therapeutic window over hypolocomotion, sedation, and catalepsy and no observable conditioned place preference. These findings suggest that unique cannabinoid chemotypes may disentangle characteristic cannabinoid side-effects from analgesia, supporting the further development of cannabinoids as pain therapeutics.

Year:

2025

Tetrahydrocannabinol (THC) is the principal psychoactive compound derived from the cannabis plant Cannabis sativa and approved for emetic conditions, appetite stimulation and sleep apnea relief. THC’s psychoactive actions are mediated primarily by the cannabinoid receptor CB 1 . Here, we determine the cryo-EM structure of HU210, a THC analog and widely used tool compound, bound to CB 1 and its primary transducer, G i1 . We leverage this structure for docking and 1000 ns molecular dynamics simulations of THC and 10 structural analogs delineating their spatiotemporal interactions at the molecular level. Furthermore, we pharmacologically profile their recruitment of G i and β-arrestins and reversibility of binding from an active complex. By combining detailed CB 1 structural information with molecular models and signaling data we uncover the differential spatiotemporal interactions these ligands make to receptors governing potency, efficacy, bias and kinetics. This may help explain the actions of abused substances, advance fundamental receptor activation studies and design better medicines.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (15)

Andrea G. Hohmann

Linda and Jack Gill Chair and Professor

Indiana University Bloomington

UNITED STATES
View details

Poul Nissen

Vice-Dean for Research

Aarhus University

DENMARK
View details

Zheng-Xiong Xi

National Institute on Drug Abuse Intramural Research Program

UNITED STATES
View details

Christos Iliopoulos_Tsoutsouvas

Research Assistant Professor

Northeastern University

UNITED STATES
View details

Thomas Boesen

Aarhus University

DENMARK
View details

Fangyu Liu

Assistant Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Michael Gajhede

Professor

Københavns Universitet

DENMARK
View details

David Gloriam

Københavns Universitet

DENMARK
View details

Laura Bohn

Professor, Associate Dean of Basic and Translational Medicine

Scripps Florida

UNITED STATES
View details

Vsevolod Katritch

University of Southern California

UNITED STATES
View details

Ken Mackie

University of Washington Medical Center

UNITED STATES
View details

Evan O'Brien

Assistant Professor

Johns Hopkins University

UNITED STATES
View details

Dmitry Veprintsev

Professor of Molecular and Cellular Pharmacology

University of Nottingham

UNITED KINGDOM
View details

Mario van der Stelt

-

NETHERLANDS
View details

Fei Tong

Northeastern University

UNITED STATES
View details